Archives

by in
Entry Author Date Location
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today 11/06/13 Boston
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Biogen’s Oral MS Drug Tops Estimates, Brings in $192M in First Quarter 07/25/13 Boston
Agios Rockets to $29 Per Share in Market Debut 07/24/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Living Proof Receives $30,000,000 New Financing Round 02/22/13 Boston
With $30M in Financing, Living Proof Primps for More Good Hair Days 02/21/13 Boston
UnitedHealth Unit Buys Boston Health IT Firm Humedica 01/25/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
Radius Health Seeks $86M IPO 02/07/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News 02/01/12 Boston
Verastem Bucks the Trend, Raises $55M in IPO 01/26/12 Boston
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments 01/11/12 New York
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News 06/22/11 Boston
Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs 06/21/11 Boston
Anthera Raises $47M 06/03/11 San Francisco
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News 04/27/11 Boston
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News 04/22/11 Boston
Page 1 of 2 next page »